Jafron Biomedical Co.,Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
25.39 | 69.4 | -63.41% | 79.21 | -67.95% |
| P/S |
|
8.06 | 6.51 | 23.86% |
|
|
| P/BV |
|
5.16 | 3.96 | 30.43% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
20.05 | 11.85 | 69.22% |
|
|
| Ev/S |
|
7.6 | 5.98 | 27.25% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0385 | 0.0396 | -2.76% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
35.01 | 20.39 | 71.72% | 47.6 | -26.45% |
| ROE |
|
19.77 | 11.95 | 65.5% |
|
|
| ROA |
|
8.56 | 5.4 | 58.47% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
31.68 | 16.23 | 95.17% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.95 | 14.63 | -86.65% | 1.95 | 0% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
2.16 | 3.6 | -40.07% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
6.95/10
|
2.78 | 1.83 | 51.67% | 1.33 | +109.37% |
| Number of years of dividend growth |
|
0 | 1.44 | -100% | ||
| DSI |
|
0.9286 | 0.9113 | 1.89% |
|
|
| Average dividend growth |
|
25.93 | 10.4 | 149.46% |
|
|
| Average percentage for 5 years |
|
1.33 | 1.14 | 16.26% |
|
|
| Average percentage for payments |
|
54.82 | 44.8 | 22.37% |
|
|
| Difference from average difference in sector |
|
0.947 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
34.26 | 61.43 | -44.23% | ||
| Growth impulse Ebitda in 5 years |
|
127.68 | 158.62 | -19.51% | ||
| Growth impulse Net Income in 5 years |
|
-23.53 | 66.93 | -135.16% | ||
| Growth impulse FCF in 5 years |
|
84.52 | 248.41 | -65.98% | ||
| Growth impulse EPS in 5 years |
|
2180.43 | 73.29 | 2875.07% |
IP Score
6.57/10
